Pharma 'greed' emerges as a potent political issue in a raucous election year
Pharma execs aren’t the most popular people in the US these days, particularly when they keep hiking the price of their drugs. And a senate campaign in New Jersey is driving that point home — right to the hilt.
Over the last few days Bob Hugin’s political opponents fighting the Republican ex-Celgene CEO’s campaign in New Jersey have been running a bitter ad spot featuring cancer survivor Pam Holt. Holt notes that Celgene’s Revlimid costs a dollar a pill to make, and Celgene charges $600 for it, after more than doubling what it originally cost when it hit the market.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.